{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825893676446464.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.clinthera.2012.04.013"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0149291812002755?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0149291812002755?httpAccept=text/plain"}}],"dc:title":[{"@value":"Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825893676446470","@type":"Researcher","foaf:name":[{"@value":"Vanita R. Aroda"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676446464","@type":"Researcher","foaf:name":[{"@value":"Robert R. Henry"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676446469","@type":"Researcher","foaf:name":[{"@value":"Jenny Han"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676446468","@type":"Researcher","foaf:name":[{"@value":"Wenying Huang"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676446465","@type":"Researcher","foaf:name":[{"@value":"Mary Beth DeYoung"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676446466","@type":"Researcher","foaf:name":[{"@value":"Tamara Darsow"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676446467","@type":"Researcher","foaf:name":[{"@value":"Byron J. Hoogwerf"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01492918"}],"prism:publicationName":[{"@value":"Clinical Therapeutics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2012-06","prism:volume":"34","prism:number":"6","prism:startingPage":"1247","prism:endingPage":"1258.e22"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://creativecommons.org/licenses/by-nc-nd/3.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0149291812002755?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0149291812002755?httpAccept=text/plain"}],"createdAt":"2012-05-18","modifiedAt":"2025-09-27","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001335983933952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study"},{"@value":"Vildagliptin vs liraglutide as a second‐line therapy switched from sitagliptin‐based regimens in patients with type 2 diabetes: A randomized, parallel‐group study"}]},{"@id":"https://cir.nii.ac.jp/crid/1050282810812307840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion"},{"@value":"Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon‐like peptide‐2 secretion"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216091125632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The inactivation of extracellular signal-regulated kinase by glucagon-like peptide-1 contributes to neuroprotection against oxidative stress"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693999215360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182505089664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206301028352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390286981362957952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Roles of Epicardial Adipose Tissue in the Pathogenesis of Coronary Atherosclerosis　― An Update on Recent Findings ―"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.clinthera.2012.04.013"},{"@type":"CROSSREF","@value":"10.1111/jdi.12269_references_DOI_3iQbMp63nE3rLaDxig4o1EsAnMs"},{"@type":"CROSSREF","@value":"10.1016/j.vph.2017.03.003_references_DOI_3iQbMp63nE3rLaDxig4o1EsAnMs"},{"@type":"CROSSREF","@value":"10.1194/jlr.m059469_references_DOI_3iQbMp63nE3rLaDxig4o1EsAnMs"},{"@type":"CROSSREF","@value":"10.1111/jdi.12289_references_DOI_3iQbMp63nE3rLaDxig4o1EsAnMs"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-20-0935_references_DOI_3iQbMp63nE3rLaDxig4o1EsAnMs"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej14-0602_references_DOI_3iQbMp63nE3rLaDxig4o1EsAnMs"},{"@type":"CROSSREF","@value":"10.1016/j.neulet.2016.01.052_references_DOI_3iQbMp63nE3rLaDxig4o1EsAnMs"}]}